Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rev. méd. Chile ; 150(4): 505-511, abr. 2022. ilus, tab
Article in Spanish | LILACS | ID: biblio-1409818

ABSTRACT

This article reviews the pulmonary manifestations of anti-neutrophil cytoplasmic antibody associated vasculitis (AAV). Its frequency in the different phenotypes of the disease, clinical manifestations and updated therapeutic recommendations are reviewed, aiming to alert the medical community about the existence of these diseases. We pretend to stimulate a timely suspicion, diagnostic precision, and the implementation of effective therapies, to reduce the eventual sequelae derived from a diagnostic omission or an inappropriate treatment for the different clinical scenarios in which these diseases appear.


Subject(s)
Humans , Antibodies, Antineutrophil Cytoplasmic , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy , Lung
2.
Rev. méd. Chile ; 149(4): 559-569, abr. 2021. tab, ilus
Article in Spanish | LILACS | ID: biblio-1389495

ABSTRACT

Approximately 5% of COVID-19 patients will have a severe disease requiring invasive or non-invasive mechanical ventilation. In this conditions, sedatives and analgesics are fundamental to promote tolerance, comfort and synchrony with the mechanical ventilator. High and unusual requirements for sedation, analgesics and neuromuscular blockers have been reported in these patients, contributing to prolonged exposure, a high rate of delirium and prolongation of mechanical ventilation. These factors, added to the progressive shortage of these drugs, a high demand for care and less capacity for personalized attention, have created an adverse scenario for their proper and rational use. This paper proposes different pharmacotherapeutic optimization strategies for a rational management of sedation, analgesia and neuromuscular block in critically ill patients with COVID-19, with the therapeutic alternatives available in Chile.


Subject(s)
Humans , COVID-19 , Analgesia , Respiration, Artificial , Chile , Critical Illness/therapy , SARS-CoV-2 , Hypnotics and Sedatives
3.
Rev. méd. Chile ; 148(11)nov. 2020.
Article in English | LILACS | ID: biblio-1389252

ABSTRACT

ABSTRACT Background: During the first pandemic wave, Covid-19 reached Latin America cities. Aim: To report clinical features and outcomes of a group of patients with Covid-19 admitted to a Chilean regional reference Center. Material and Methods: Cases were identified by a compatible clinical picture and a positive PCR or serological test. Clinical features of patients were retrieved from medical records. Results: Forty-seven adult patients (45 diagnosed by PCR, 2 by serology) were admitted between epidemiological weeks 13 to 33, corresponding to 4.4% of total regional cases. Hospitalization occurred at a median of 10 days after onset of symptoms. Fifty one percent of patients had 60 years or more. Hypertension, obesity and diabetes mellitus were present in 57, 45 and 32 % of cases, respectively. Nineteen percent of patients had no comorbid condition nor were elderly. Two cases were women in their second trimester of pregnancy. Positive IgM or IgM/IgG results obtained by rapid serological testing, had limited sensitivity during the first week (67%). Seventeen patients (36.2%) were transferred to an intensive care unit (ICU) due to respiratory failure. Chest imaging demonstrated a classical COVID-19 pattern in 87%. By univariate analysis, admission to ICU was significantly associated with tachypnea and higher CALL (comorbidity, age, lymphocyte count and lactate dehydrogenase) score. Four patients died (rendering a hospital mortality of 8.5%) and length of stay was ≥ 14 days in 46.8% of patients. By univariate analysis, mortality was associated with immunosuppression and ICU admission. Conclusions: In our regional Center, patients admitted with COVID-19 had usual risk factors and had a prolonged stay. Hospital mortality was associated with immunosuppression and ICU admission.


Antecedentes: Durante la primera ola pandémica, COVID-19 llegó a las ciudades de América Latina. Objetivos: Informar las características clínicas y los resultados asociados a COVID-19 en un grupo de pacientes ingresados en un Centro de referencia regional en el sur de Chile. Material y Métodos: Los casos fueron identificados por un cuadro clínico compatible asociado a RT-PCR positiva o prueba serológica. La información clínica de los pacientes se obtuvo de sus fichas. Resultados: Entre las semanas epidemiológicas 13 y 33 ingresaron 47 pacientes adultos (45 diagnosticados por PCR, 2 por serología), lo que representa el 4,4% del total de casos regionales. La hospitalización se produjo con una mediana de 10 días después del inicio de los síntomas. El 51% de los pacientes tenía 60 años o más. La hipertensión arterial (57,4%), la obesidad (44,7%) y la diabetes mellitus 2 (31,9%) fueron prevalentes, pero el 19% no presentaba comorbilidades ni era un adulto mayor. Dos casos ocurrieron en mujeres embarazadas en el segundo trimestre. Los resultados positivos de IgM o IgM / IgG obtenidos mediante pruebas serológicas rápidas tuvieron una sensibilidad limitada durante la primera semana (66,7%). Diecisiete pacientes (36,2%, grupo crítico) fueron trasladados a UCI por insuficiencia respiratoria. Las imágenes de tórax demostraron un patrón COVID-19 clásico en el 87% de los casos. Por análisis univariado, el ingreso en UCI se asoció significativamente con taquipnea y puntuaciones CALL (comorbidity, age, lymphocyte count and lactate dehydrogenase) elevadas. Cuatro pacientes fallecieron (mortalidad hospitalaria 8,5%) y la estadía hospitalaria fue ≥ 14 días en el 47% de los pacientes. Por análisis univariado la mortalidad se asoció a inmunodepresión y al ingreso a UCI. Conclusiones: En nuestro Centro regional, COVID-19 se asoció a factores de riesgo conocidos y tuvo una estadía prolongada. La mortalidad hospitalaria se asoció con inmunosupresión o ingreso a UCI.


Subject(s)
Adult , Aged , Female , Humans , Pregnancy , COVID-19 , Chile/epidemiology , Critical Illness , SARS-CoV-2 , Hospitalization , Intensive Care Units
4.
Rev. chil. med. intensiv ; 28(1): 7-12, 2013. tab, graf
Article in Spanish | LILACS | ID: biblio-831368

ABSTRACT

Introducción: La estructura organizacional de las Unidades de Cuidados Intensivos está basada en turnos, con cambios en los equipos durante la noche y los fines de semana-festivos (FdS-F). Se ha descrito una mayor mortalidad en los ingresos realizados durante estos períodos. Nuestro objetivo es evaluar si la mortalidad de los pacientes ingresados a nuestra unidad se ve influenciada porel horario nocturno o los FdS-F. Metodología: Estudio retrospectivo de la cohorte de pacientes ingresados desde el 1 de enero al 31 de diciembre de 2011 en el Hospital Clínico Regional Valdivia. Se consideró turno día (TD)el comprendido entre las 08:00 AM y las 20:59 PM, y el turno noche (TN) entre las 21:00 y las 07:59 horas. Se asignó como horario de fin de semana al comprendido entre el día viernes a las21:00 horas y el lunes a las 07:59. Dentro de esta misma categoría se incluyeron los festivos, con el mismo rango horario descrito. Base de datos en Excel MAC y análisis estadístico con Vassar Stats. Resultados: Durante el año 2011, se produjeron 425 ingresos, con una mortalidad global de 25 por ciento, variando según el tipo de patología que motivó el ingreso a la unidad (sepsis 45 por ciento, cardiovascular 17 por ciento, respiratorio 30 por ciento, neurológico 26 por ciento, trauma 24 por ciento, digestivo 32 por ciento, renal 14 por ciento, otras 18 por ciento). Los principales motivos de ingreso fueron las patologías cardiovasculares (32 por ciento), sepsis (18 por ciento) y enfermedades respiratorias (14 por ciento). El 51 por ciento requirió de Ventilación Mecánica Invasiva. El tiempo de estadía fue una mediana de 3 días (0-80). El 48 por ciento de los pacientes ingresó en el horario de TD, 38 por ciento en TN, sin contar con la hora de ingreso en el 14 por ciento de los casos. La mortalidad de los pacientes ingresados en TN fue 30 por ciento y los ingresados en TD 25 por ciento (OR 1,29 IC 95 por ciento 0,8126-2,0393; p= 0,29)...


Introduction: The job in most of Intensive Care Units (ICU) is organized in shift work, this system includes the activities performed during nights and weekends or holidays (W-HD). Higher mortality has been described in patients admitted at nights and W-HD. We decided to study if mortality in our unit was related to the admission during these periods. Methods: We reviewed the clinical records of patients admitted at the ICU of Valdivia Hospital since January 31, 2011 to December 31, 2011. Day shift (DS) was defined between 8:00 and 20:59 hours, night shift (NS) between 21:00 and 7:59 hours, weekend was considered as the period between Friday at 21:00hours and Monday at 7:59 and finally, holiday was considered as the period between the previous date at 21:00 and next day at 7:59 hours of a non-laboral day. Data were analyzed with Microsoft EXCEL for Mac and Vassar stats software. Results: four hundred twenty five patients were admitted at the ICU during this period, the mortality was 25 percent. It was different according with type of disease (sepsis 45 percent, cardiovascular disease 17 percent, respiratory disease 30 percent, neurologic disease 26 percent, trauma 24 percent, gastrointestinal disease 32 percent, renal disease 14 percent, others 18 percent). The most frequent causes of admission were cardiovascular diseases (32 percent), sepsis (19 percent) and respiratory diseases (14 percent). 51 percent of patients were submitted to mechanical ventilation. The median of staying in the unit was 3 days (0-80 days). 48 percent of patients were entered at the unit at DS, 38 percent at NS and in 14 percent of cases the time of admission was not registered. Mortality of patients admitted was 30 percent in NS and 25 percent in DS (OR 1,29 CI 95 percent 0,8126-2,0393; p=0,29)...


Subject(s)
Humans , Patient Admission/statistics & numerical data , Hospital Mortality , Intensive Care Units/statistics & numerical data , Cause of Death , Chile , Retrospective Studies , Time Factors
5.
Rev. chil. med. intensiv ; 26(1): 7-16, 2011. tab, graf
Article in Spanish | LILACS | ID: lil-669028

ABSTRACT

En la primera pandemia del siglo XXI por virus influenza A/H1N1, una importante proporción de paciente que desarrollaron neumonía y Falla Respiratoria Aguda (FRA) eran obesos. La obesidad ha sido propuesta como un factor de riesgo que aumenta la morbimortalidad; sin embargo, hay controversia al respecto. Objetivo: evaluar el impacto de la obesidad en complicaciones, estadía y/o mortalidad en pacientes adultos graves por virus influenza A/H1N1. Estudio observacional y multicéntrico realizado en 17 UCIs de Chile durante el periodo mayo-agosto 2009. Fueron incluidos en el estudio solo paciente con infección por virus Influenza A/H1N1 confirmada o probable. Los paciente obesos (IMC>30) fueron comparados con pacientes no obesos. Resultados: De un total de 136 pacientes incluidos en el estudio, 64 (47 por ciento) fueron obesos y de estos 13 obesos mórbidos (BMI >40). Los pacientes obesos tienen mayor frecuencia de: comorbilidades, ventilación mecánica y complicaciones. La estadía en UCI y en el hospital fue más prolongada en pacientes obesos (18,1+/-15 vs. 10,9+/-10,2, p=0,002 y 27,2+/-24,7 vs17,7 +/- 14,6, p=0,01 respectivamente). La mortalidad fue mayor en pacientes obesos (36 por ciento vs. 19,4 por ciento; OR 2,32; IC95 por ciento 1,07-5,05, p=0.035). El estudio de regresión logística encuentra que la FOM es un factor pronóstico independiente de mortalidad en pacientes obesos. Conclusiones: Los pacientes obesos con neumonía grave por virus influenza A/H1N1 tienen una mayor morbi-mortalidad y prolongación de su estadía en UCI y en el hospital. El desarrollo de FOM en pacientes obesos es un factor de mal pronóstico.


In the first pandemic of the 21st century due to influenza A/H1N1 virus, a significant proportion of patients who developed pneumonia and acute respiratory failure (ARF) were obese. Obesity has been proposed as a risk factor that increases morbidity and mortality, however, there is controversy about it. Objective: To determine the impact of obesity on complications, stay and / or mortality in adult patients with severe influenza A/H1N1 virus. Multicenter observational study conducted in 17 ICUs of Chile during the period May to August 2009. Were included only patients with influenza A/H1N1 virus infection confirmed or probable. Obese patients (BMI> 30) were compared with non obese patients. The results: Of a total of 136 patients included in the study, 64 (47 percent) were obese and of these 13 morbidly obese (BMI> 40). Obese patients have a higher frequency of: comorbidities, mechanical ventilation and complications. The stay in ICU and hospital was longer in obese patients (18.1 +/- 15 vs. 10.9 +/- 10.2, p = 0.002 and 27.2 +/- 24.7 vs17, 7 +/- 14.6, p = 0.01 respectively). Mortality was higher in obese patients (36 percent vs. 19.4 percent, OR 2.32, 95 percent CI 1.07 to 5.05, p = 0,035). The logistic regression analysis found that the MOF is an independent predictor of mortality in obese patients. Conclusions: Obese patients with severe pneumonia due to the influenza A/H1N1 virus have a high morbidity and mortality and prolonged stay in ICU and hospital. MOF development in obese patients is a poor prognostic factor.


Subject(s)
Humans , Male , Adolescent , Adult , Female , Middle Aged , Influenza, Human/epidemiology , Pneumonia, Viral/epidemiology , Obesity/epidemiology , Body Mass Index , Comorbidity , Chile/epidemiology , Influenza, Human/mortality , Influenza, Human/virology , Intensive Care Units , Length of Stay , Logistic Models , Multicenter Studies as Topic , Pneumonia, Viral/mortality , Obesity/complications , Obesity/mortality , Survival Analysis , Influenza A Virus, H1N1 Subtype/isolation & purification
6.
Rev. chil. med. intensiv ; 23(1): 43-48, 2008. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-516208

ABSTRACT

La sepsis grave en pacientes quirúrgicos tiene una mortalidad elevada. Hay evidencias que el uso de proteína C activada recombinante (Drotrecogin alfa) mejora la sobrevida en estos pacientes. Presentamos el caso de un hombre de 40 años con síndrome de Marfán sometido a cirugía cardiaca valvular que desarrolla sepsis grave por lo cual se administra proteína C activada recombinante con resultados favorables.


Severe sepsis in surgical patients has a high mortality. There is evidence that the use of recombinant human activated protein C (Drotrecogin alfa) improves survival in these patients. We report the use of drotrecogin alfa, in a 40-year-old male with Marfan’s syndrome undergone cardiac valve surgery that develops severe sepsis, with good results.


Subject(s)
Humans , Male , Middle Aged , Protein C/therapeutic use , Recombinant Proteins/therapeutic use , Sepsis/drug therapy , Postoperative Period
SELECTION OF CITATIONS
SEARCH DETAIL